- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Influenza (Flu) Antiviral Drugs will have significant change from previous year. By the most conservative estimates of global Influenza (Flu) Antiviral Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Influenza (Flu) Antiviral Drugs market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza (Flu) Antiviral Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Influenza (Flu) Antiviral Drugs, covering the supply chain analysis, impact assessment to the Influenza (Flu) Antiviral Drugs market size growth rate in several scenarios, and the measures to be undertaken by Influenza (Flu) Antiviral Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Penetration and Dehulling Inhibitors
DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protein Inhibitors
Neuraminidase Inhibitors
Broad-spectrum Antiviral Drugs
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Hospital
Clinic
Household
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Amgen
Roche
Johnson & Johnson
Merck & Co. (MSD)
Sanofi
Gilead Sciences
Novartis
GlaxoSmithKline (GSK)
AbbVie
Novo Nordisk
Takeda
Allergan
AstraZeneca
Teva
Eli Lilly
Bayer
Bristol-Myers Squibb
Boehringer Ingelheim
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Influenza (Flu) Antiviral Drugs market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Influenza (Flu) Antiviral Drugs market by identifying its various subsegments.
Focuses on the key global Influenza (Flu) Antiviral Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Influenza (Flu) Antiviral Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Influenza (Flu) Antiviral Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Influenza (Flu) Antiviral Drugs?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Influenza (Flu) Antiviral Drugs Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza (Flu) Antiviral Drugs Market Size 2015-2025
2.1.2 Influenza (Flu) Antiviral Drugs Market Size CAGR by Region
2.2 Influenza (Flu) Antiviral Drugs Segment by Type
2.2.1 Penetration and Dehulling Inhibitors
2.2.2 Penetration and Dehulling Inhibitors
2.2.3 Reverse Transcriptase Inhibitors
2.2.4 Protein Inhibitors
2.2.5 Neuraminidase Inhibitors
2.2.6 Broad-spectrum Antiviral Drugs
2.3 Influenza (Flu) Antiviral Drugs Market Size by Type
2.3.1 Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2015-2020)
2.3.2 Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Type (2015-2020)
2.4 Influenza (Flu) Antiviral Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Household
2.4.4 Others
2.5 Influenza (Flu) Antiviral Drugs Market Size by Application
2.5.1 Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2015-2020)
2.5.2 Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Application (2015-2020)
3 Global Influenza (Flu) Antiviral Drugs by Players
3.1 Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Players
3.1.1 Global Influenza (Flu) Antiviral Drugs Market Size by Players (2018-2020)
3.1.2 Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Players (2018-2020)
3.2 Global Influenza (Flu) Antiviral Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Influenza (Flu) Antiviral Drugs by Regions
4.1 Influenza (Flu) Antiviral Drugs Market Size by Regions
4.2 Americas Influenza (Flu) Antiviral Drugs Market Size Growth
4.3 APAC Influenza (Flu) Antiviral Drugs Market Size Growth
4.4 Europe Influenza (Flu) Antiviral Drugs Market Size Growth
4.5 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Growth
5 Americas
5.1 Americas Influenza (Flu) Antiviral Drugs Market Size by Countries
5.2 Americas Influenza (Flu) Antiviral Drugs Market Size by Type
5.3 Americas Influenza (Flu) Antiviral Drugs Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Influenza (Flu) Antiviral Drugs Market Size by Regions
6.2 APAC Influenza (Flu) Antiviral Drugs Market Size by Type
6.3 APAC Influenza (Flu) Antiviral Drugs Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Influenza (Flu) Antiviral Drugs by Countries
7.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Type
7.3 Europe Influenza (Flu) Antiviral Drugs Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Influenza (Flu) Antiviral Drugs by Countries
8.2 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Type
8.3 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Influenza (Flu) Antiviral Drugs Market Forecast
10.1 Global Influenza (Flu) Antiviral Drugs Market Size Forecast (2021-2025)
10.2 Global Influenza (Flu) Antiviral Drugs Forecast by Regions
10.2.1 Global Influenza (Flu) Antiviral Drugs Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Influenza (Flu) Antiviral Drugs Forecast by Type
10.8 Global Influenza (Flu) Antiviral Drugs Forecast by Application
11 Key Players Analysis
11.1 Pfizer
11.1.1 Company Details
11.1.2 Influenza (Flu) Antiviral Drugs Product Offered
11.1.3 Pfizer Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Pfizer News
11.2 Amgen
11.2.1 Company Details
11.2.2 Influenza (Flu) Antiviral Drugs Product Offered
11.2.3 Amgen Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Amgen News
11.3 Roche
11.3.1 Company Details
11.3.2 Influenza (Flu) Antiviral Drugs Product Offered
11.3.3 Roche Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Roche News
11.4 Johnson & Johnson
11.4.1 Company Details
11.4.2 Influenza (Flu) Antiviral Drugs Product Offered
11.4.3 Johnson & Johnson Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Johnson & Johnson News
11.5 Merck & Co. (MSD)
11.5.1 Company Details
11.5.2 Influenza (Flu) Antiviral Drugs Product Offered
11.5.3 Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Merck & Co. (MSD) News
11.6 Sanofi
11.6.1 Company Details
11.6.2 Influenza (Flu) Antiviral Drugs Product Offered
11.6.3 Sanofi Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Sanofi News
11.7 Gilead Sciences
11.7.1 Company Details
11.7.2 Influenza (Flu) Antiviral Drugs Product Offered
11.7.3 Gilead Sciences Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Gilead Sciences News
11.8 Novartis
11.8.1 Company Details
11.8.2 Influenza (Flu) Antiviral Drugs Product Offered
11.8.3 Novartis Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Novartis News
11.9 GlaxoSmithKline (GSK)
11.9.1 Company Details
11.9.2 Influenza (Flu) Antiviral Drugs Product Offered
11.9.3 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 GlaxoSmithKline (GSK) News
11.10 AbbVie
11.10.1 Company Details
11.10.2 Influenza (Flu) Antiviral Drugs Product Offered
11.10.3 AbbVie Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 AbbVie News
11.11 Novo Nordisk
11.12 Takeda
11.13 Allergan
11.14 AstraZeneca
11.15 Teva
11.16 Eli Lilly
11.17 Bayer
11.18 Bristol-Myers Squibb
11.19 Boehringer Ingelheim
12 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Influenza (Flu) Antiviral Drugs Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Influenza (Flu) Antiviral Drugs Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Influenza (Flu) Antiviral Drugs Market Size CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Penetration and Dehulling Inhibitors
Table 7. Major Players of DNA Polymerase Inhibitors
Table 8. Major Players of Reverse Transcriptase Inhibitors
Table 9. Major Players of Protein Inhibitors
Table 10. Major Players of Neuraminidase Inhibitors
Table 11. Major Players of Broad-spectrum Antiviral Drugs
Table 12. Influenza (Flu) Antiviral Drugs Market Size by Type (2014-2019) ($ Millions)
Table 13. Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2015-2020)
Table 14. Global Influenza (Flu) Antiviral Drugs Market Size by Application (2015-2020) ($ Millions)
Table 15. Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2015-2020)
Table 16. Global Influenza (Flu) Antiviral Drugs Revenue by Players (2018-2020) ($ Millions)
Table 17. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Players (2018-2020)
Table 18. Global Influenza (Flu) Antiviral Drugs Key Players Head office and Products Offered
Table 19. Influenza (Flu) Antiviral Drugs Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Influenza (Flu) Antiviral Drugs Market Size by Regions 2015-2020 ($ Millions)
Table 23. Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Regions 2015-2020
Table 24. Americas Influenza (Flu) Antiviral Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 25. Americas Influenza (Flu) Antiviral Drugs Market Size Market Share by Countries (2015-2020)
Table 26. Americas Influenza (Flu) Antiviral Drugs Market Size by Type (2015-2020) ($ Millions)
Table 27. Americas Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2015-2020)
Table 28. Americas Influenza (Flu) Antiviral Drugs Market Size by Application (2015-2020) ($ Millions)
Table 29. Americas Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2015-2020)
Table 30. APAC Influenza (Flu) Antiviral Drugs Market Size by Regions (2015-2020) ($ Millions)
Table 31. APAC Influenza (Flu) Antiviral Drugs Market Size Market Share by Regions (2015-2020)
Table 32. APAC Influenza (Flu) Antiviral Drugs Market Size by Type (2015-2020) ($ Millions)
Table 33. APAC Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2015-2020)
Table 34. APAC Influenza (Flu) Antiviral Drugs Market Size by Application (2015-2020) ($ Millions)
Table 35. APAC Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2015-2020)
Table 36. Europe Influenza (Flu) Antiviral Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 37. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Countries (2015-2020)
Table 38. Europe Influenza (Flu) Antiviral Drugs Market Size by Type (2015-2020) ($ Millions)
Table 39. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2015-2020)
Table 40. Europe Influenza (Flu) Antiviral Drugs Market Size by Application (2015-2020) ($ Millions)
Table 41. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2015-2020)
Table 42. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 43. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Type (2015-2020) ($ Millions)
Table 45. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2015-2020)
Table 46. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Application (2015-2020) ($ Millions)
Table 47. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2015-2020)
Table 48. Key and Potential Regions of Influenza (Flu) Antiviral Drugs
Table 49. Key Application and Potential Industries of Influenza (Flu) Antiviral Drugs
Table 50. Key Challenges of Influenza (Flu) Antiviral Drugs
Table 51. Key Trends of Influenza (Flu) Antiviral Drugs
Table 52. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 53. Global Influenza (Flu) Antiviral Drugs Market Size Market Share Forecast by Regions
Table 54. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Type (2021-2025) ($ Millions)
Table 55. Global Influenza (Flu) Antiviral Drugs Market Size Market Share Forecast by Type (2021-2025)
Table 56. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Application (2021-2025) ($ Millions)
Table 57. Global Influenza (Flu) Antiviral Drugs Market Size Market Share Forecast by Application (2021-2025)
Table 58. Pfizer Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 59. Pfizer Influenza (Flu) Antiviral Drugs Product Offered
Table 60. Pfizer Influenza (Flu) Antiviral Drugs Revenue and Gross Margin (2018-2020E)
Table 61. Pfizer Main Business
Table 62. Pfizer Latest Developments
Table 63. Amgen Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 64. Amgen Influenza (Flu) Antiviral Drugs Product Offered
Table 65. Amgen Main Business
Table 66. Amgen Influenza (Flu) Antiviral Drugs Revenue and Gross Margin (2018-2020E)
Table 67. Amgen Latest Developments
Table 68. Roche Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 69. Roche Influenza (Flu) Antiviral Drugs Product Offered
Table 70. Roche Main Business
Table 71. Roche Influenza (Flu) Antiviral Drugs Revenue and Gross Margin (2018-2020E)
Table 72. Roche Latest Developments
Table 73. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 74. Johnson & Johnson Influenza (Flu) Antiviral Drugs Product Offered
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Influenza (Flu) Antiviral Drugs Revenue and Gross Margin (2018-2020E)
Table 77. Johnson & Johnson Latest Developments
Table 78. Merck & Co. (MSD) Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 79. Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Product Offered
Table 80. Merck & Co. (MSD) Main Business
Table 81. Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Revenue and Gross Margin (2018-2020E)
Table 82. Merck & Co. (MSD) Latest Developments
Table 83. Sanofi Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 84. Sanofi Influenza (Flu) Antiviral Drugs Product Offered
Table 85. Sanofi Main Business
Table 86. Sanofi Influenza (Flu) Antiviral Drugs Revenue and Gross Margin (2018-2020E)
Table 87. Sanofi Latest Developments
Table 88. Gilead Sciences Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 89. Gilead Sciences Influenza (Flu) Antiviral Drugs Product Offered
Table 90. Gilead Sciences Main Business
Table 91. Gilead Sciences Influenza (Flu) Antiviral Drugs Revenue and Gross Margin (2018-2020E)
Table 92. Gilead Sciences Latest Developments
Table 93. Novartis Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 94. Novartis Influenza (Flu) Antiviral Drugs Product Offered
Table 95. Novartis Main Business
Table 96. Novartis Influenza (Flu) Antiviral Drugs Revenue and Gross Margin (2018-2020E)
Table 97. Novartis Latest Developments
Table 98. GlaxoSmithKline (GSK) Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 99. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product Offered
Table 100. GlaxoSmithKline (GSK) Main Business
Table 101. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Revenue and Gross Margin (2018-2020E)
Table 102. GlaxoSmithKline (GSK) Latest Developments
Table 103. AbbVie Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 104. AbbVie Influenza (Flu) Antiviral Drugs Product Offered
Table 105. AbbVie Main Business
Table 106. AbbVie Influenza (Flu) Antiviral Drugs Revenue and Gross Margin (2018-2020E)
Table 107. AbbVie Latest Developments
Table 108. Novo Nordisk Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 109. Takeda Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 110. Allergan Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 111. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 112. Teva Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 113. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 114. Bayer Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 115. Bristol-Myers Squibb Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
Table 116. Boehringer Ingelheim Details, Company Total Revenue (in $ million), Head Office, Influenza (Flu) Antiviral Drugs Major Market Areas and Its Competitors
List of Figures
Figure 1. Influenza (Flu) Antiviral Drugs Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2015-2020)
Figure 5. Global Penetration and Dehulling Inhibitors Market Size Growth Rate
Figure 6. Global DNA Polymerase Inhibitors Market Size Growth Rate
Figure 7. Global Reverse Transcriptase Inhibitors Market Size Growth Rate
Figure 8. Global Protein Inhibitors Market Size Growth Rate
Figure 9. Global Neuraminidase Inhibitors Market Size Growth Rate
Figure 10. Global Broad-spectrum Antiviral Drugs Market Size Growth Rate
Figure 11. Influenza (Flu) Antiviral Drugs in Hospital
Figure 12. Global Influenza (Flu) Antiviral Drugs Market: Hospital (2015-2020) ($ Millions)
Figure 13. Influenza (Flu) Antiviral Drugs in Clinic
Figure 14. Global Influenza (Flu) Antiviral Drugs Market: Clinic (2015-2020) ($ Millions)
Figure 15. Influenza (Flu) Antiviral Drugs in Household
Figure 16. Global Influenza (Flu) Antiviral Drugs Market: Household (2015-2020) ($ Millions)
Figure 17. Global Household YoY Growth ($ Millions)
Figure 18. Influenza (Flu) Antiviral Drugs in Others
Figure 19. Global Influenza (Flu) Antiviral Drugs Market: Others (2015-2020) ($ Millions)
Figure 20. Global Others YoY Growth ($ Millions)
Figure 21. Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Application in 2019
Figure 22. Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Regions 2015-2020
Figure 23. Americas Influenza (Flu) Antiviral Drugs Market Size 2015-2020 ($ Millions)
Figure 24. APAC Influenza (Flu) Antiviral Drugs Market Size 2015-2020 ($ Millions)
Figure 25. Europe Influenza (Flu) Antiviral Drugs Market Size 2015-2020 ($ Millions)
Figure 26. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size 2015-2020 ($ Millions)
Figure 27. Americas Influenza (Flu) Antiviral Drugs Market Size Market Share by Countries in 2019
Figure 28. Americas Influenza (Flu) Antiviral Drugs Market Size Market Share by Type in 2019
Figure 29. Americas Influenza (Flu) Antiviral Drugs Market Size Market Share by Application in 2019
Figure 30. United States Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 31. Canada Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 32. Mexico Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 33. APAC Influenza (Flu) Antiviral Drugs Market Size Market Share by Regions in 2019
Figure 34. APAC Influenza (Flu) Antiviral Drugs Market Size Market Share by Type in 2019
Figure 35. APAC Influenza (Flu) Antiviral Drugs Market Size Market Share by Application in 2019
Figure 36. China Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 37. Japan Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 38. Korea Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 39. Southeast Asia Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 40. India Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 41. Australia Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 42. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Countries in 2019
Figure 43. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Type in 2019
Figure 44. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Application in 2019
Figure 45. Germany Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 46. France Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 47. UK Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 48. Italy Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 49. Russia Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 50. Spain Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 51. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Countries in 2019
Figure 52. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Type in 2019
Figure 53. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Application in 2019
Figure 54. Egypt Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 55. South Africa Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 56. Israel Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 57. Turkey Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 58. GCC Countries Influenza (Flu) Antiviral Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 59. Global Influenza (Flu) Antiviral Drugs arket Size Forecast (2021-2025) ($ Millions)
Figure 60. Americas Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 61. APAC Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 62. Europe Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 63. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 64. United States Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 65. Canada Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 66. Mexico Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 67. Brazil Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 68. China Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 69. Japan Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 70. Korea Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 71. Southeast Asia Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 72. India Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 73. Australia Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 74. Germany Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 75. France Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 76. UK Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 77. Italy Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 78. Russia Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 79. Spain Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 80. Egypt Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 81. South Africa Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 82. Israel Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 83. Turkey Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Figure 84. GCC Countries Influenza (Flu) Antiviral Drugs Market Size 2021-2025 ($ Millions)
Please feel free to write an email to us or to use our electronic ticketing system.
